Urine Bag Cover
This technology introduces a disposable urine bag cover designed to enhance hygiene and operational efficiency in medical and care settings. It features an…
Cut operational costs by ~65%, boost hygiene in patient care.
~$200,000/year estimated operational cost reduction per 100 facilities (est.).
GM1 Gangliosidosis Prophylactic or Therapeutic Agent and Composition
This technology identifies known compounds as active ingredients for preventing or treating GM1 Gangliosidosis, a severe neurodegenerative rare disease. By…
Rare Disease Therapy: 4x Faster Development, ~17 Years Exclusivity
~$65M–$650M/year estimated revenue potential (est.)
PPARδ Activator and Exercise Tolerance Enhancer
This technology introduces a novel PPARδ activator using guanidine or biguanidine derivatives to specifically enhance metabolic activity. It offers a new a…
Boost Exercise Tolerance by 1.5×, Improve Metabolism
~$2M/year estimated healthcare cost reduction (est.)
Resorcinol Derivatives and Tyrosinase Activity Inhibitors Containing Them
This technology introduces novel resorcinol derivatives with significantly enhanced tyrosinase inhibitory activity, a key mechanism for reducing melanin pr…
New Resorcinol Derivative: ~2x Efficacy, 17-Year Market Exclusivity
~$33.5M/year estimated revenue expansion per facility (est.)
Superhydrophobic Surface Structure and Method for Manufacturing a Mold
This technology replicates a termite wing's microstructure to create a superhydrophobic surface that efficiently captures and recovers micro-droplets. It o…
Bio-Inspired Surface Boosts Liquid Recovery by 1.5x, Cuts Maintenance Costs by ~$150K
~$150K/year estimated maintenance cost reduction per facility (est.)
Composition with Paraprevotella Bacteria as Active Ingredient for Trypsin Activity Inhib…
This technology leverages specific Paraprevotella bacteria to inhibit trypsin activity, providing a novel, microbiome-based approach for treating, improvin…
IBD Treatment: Paraprevotella Reduces Trypsin Activity, ~$65M/year Potential
~$65 million/year estimated new market capture (est.)
Hyaluronic Acid Derivative and Method for Manufacturing Hyaluronic Acid Derivative
This novel hyaluronic acid derivative delivers potent, steroid-free anti-inflammatory action by suppressing inflammatory cytokine production. Engineered fo…
Steroid-Free HA Derivative Cuts Side Effects by ~80%, Boosts Anti-Inflammatory Action
~$3.5M/year estimated healthcare cost reduction market-wide (est.)
SN-38 Derivatives, Nanoparticles, Pharmaceuticals, and Production Methods
This innovative drug delivery system (DDS) utilizes SN-38 derivative-loaded nanoparticles for highly selective drug release directly within tumor microenvi…
1.5x Efficacy, ~66% Side Effect Reduction for Targeted Cancer Therapy
~$20M/year estimated total healthcare economic impact (AI est.)
Structure and Method for Manufacturing the Same
This technology offers a high-efficiency photocatalytic structure based on monoclinic bismuth vanadate, along with a practical manufacturing method. Its un…
3× Photocatalytic Efficiency: Mass-Produce Next-Gen Environmental Materials
~$1M/year estimated operational cost savings per facility (est.)
V-ATPase Activity Inhibitors, Antibacterial Agents, Pharmaceuticals, and Screening Metho…
This technology offers novel V-ATPase inhibitors that selectively disrupt bacterial ion balance, effectively suppressing multi-drug resistant pathogens. Ta…
AMR Breakthrough: Selective V-ATPase Inhibition Cuts Treatment Costs by ~$1.5M Annually
~$1.5M/year estimated medical cost reduction per facility (est.)
Method for Generating a Learning Model, Diagnostic Support System, and Data Acquisition …
This AI system analyzes CT images for nasal and paranasal sinus disease diagnosis. It precisely segments key regions, quantifying anomalies, bone relations…
AI-Powered CT Analysis: Boost Diagnosis Accuracy by 20%, Cut Time by 66%
~$200K/year estimated diagnostic cost reduction per facility (est.)
Alzheimer's Disease Prevention or Treatment Agent, Composition, and Method
This technology introduces a novel approach to Alzheimer's disease treatment by repurposing the approved drug amodiaquine. It targets the intracellular acc…
Novel AD Therapy: ~3 Years Faster to Market, ~$650M Annual Revenue
~$650M/year estimated market share revenue (AI est.)
Health Monitoring System and Health Monitoring Method
This innovative system combines non-invasive biometric devices with a bio-cybernetic avatar to measure and visualize internal body conditions over time. It…
Predict disease risk 20 years out, visualize health with bio-avatars.
~$1.0M/year estimated reduction in healthcare and health maintenance costs per enterprise (est.).
Finger Cot Type Bandage
This innovative finger bandage provides superior adhesion to complex finger contours, such as fingertips and joints, where traditional bandages often fail.…
New Bandage Fits Finger Joints, Cuts Application Time by 66%
~$150K/year estimated cost savings and productivity improvement per facility (est.)
Cultivation Support Device for Vine Crops
This innovative system for vine crops uses multi-layered support hammocks to increase yield by 1.5x per unit area. It eliminates strenuous bending and high…
1.5× Yield, 80% Labor Reduction in Vine Crop Cultivation
~$200K/year estimated cost savings and increased revenue per facility (est.)
Novel Superovulation Induction Method for Breeding
This technology offers a hormone-free method for inducing superovulation in non-human mammals using anti-inhibin antibodies. It significantly improves viab…
Boost Animal Breeding by ~10% with Hormone-Free Over-Ovulation
~$1M/year estimated productivity improvement and cost reduction per facility (est.)
Oral Vaccine Composition Containing Fibroin-Containing Nanoparticles
This technology enables oral vaccine delivery for animals using fibronin-containing nanoparticles. It protects antigens from degradation and ensures effici…
Oral Vaccine Transforms Animal Health: Cuts Stress by 66%, Boosts Efficiency
~$800K/year estimated operational cost reduction per facility (est.)
Method for Manufacturing Cell Aggregates
This technology precisely controls the size of cell aggregates using a gel-embedding, fragmentation, and selection process. This innovation significantly e…
Precision Size Control Boosts Cell Function by 15%, Cuts Production Costs by ~$340K/Year
~$350K/year estimated manufacturing cost reduction per facility (est.)
Compositions for Hematopoietic Tumor Therapy and Cancer Cell Growth Inhibition
This patent introduces an innovative nucleic acid delivery system for hematopoietic tumor treatment. It utilizes a unique nucleic acid analog and specific …
Hematopoietic Tumor Therapy: 95% Specificity, ~90% Side Effect Reduction
~$10M/year estimated economic impact per facility (AI est.)
Information Processing Apparatus, Information Processing Method, and Program
This technology integrates diverse time-series measurement data into a dynamic latent space, enabling highly accurate, data-driven diagnostics. It leverage…
AI-Powered Diagnosis: ~30% Faster, ~5% Fewer Reworks with Integrated Data
~$1M/year estimated cost efficiency per facility (est.)
Surface Modifying Material for Lipid Membrane Structures
This technology introduces PMPC lipids as a novel surface modifier for lipid membrane structures, such as liposomes and nanocapsules. It significantly enha…
Next-Gen Nanocarriers: ~25% Better Biocompatibility, ~30% Enhanced Stability
~$1M/year estimated cost reduction per facility (est.)
Ultrasound Imaging Apparatus
This technology uses a deformable ultrasound probe that self-corrects its shape based on imaging data, enabling high-precision scans of complex surfaces an…
Flexible Probes Eliminate Blind Spots, Boost Inspection Efficiency by ~20%
~$500K/year estimated reduction in defect losses per facility (est.)
Electrolyte-Electrode Assembly for Ammonia Electrosynthesis
This technology introduces an innovative electrolyte-electrode assembly for ammonia electrosynthesis, precisely controlling the interface between an ion-co…
Green Ammonia: ~20% Energy Savings, ~$1.5M/Year Cost Reduction
~$1.5M/year estimated manufacturing cost reduction per facility (est.)
Method and Apparatus for Muscle Fatigue Estimation
This technology uses AI and physiological simulation to precisely estimate muscle fatigue from exercise data. By modeling energy supply and chemical change…
AI Estimates Muscle Fatigue, Boosts Performance by 20%
~$450K/year (AI est.) in cost savings and productivity gains per facility.